Capricorn prepares for February showdown
The firm’s board continues to push back against opposition among some shareholders to plans for a merger with Israeli independent New Med
The dispute between London-listed Capricorn Energy’s board and shareholders over the proposed merger with Israel’s New Med is likely to come to a head in early February, with an extraordinary general meeting planned for the first of the month. The board expects to hold a “vote on the combination on or around the same date”. The shareholder revolt is being led by London-based fund Palliser Capital, which owns 6.96pc of Capricorn shares but claims that shareholders representing more than 40pc “disapprove of the New Med deal”. The fund called for a general meeting back in December, stating that it, “as required by the articles [of incorporation]... must take place by 30 January 2023 at the late

Also in this section
22 September 2023
Former executives and a successor company are accused of complicity in Sudanese war crimes in what is now South Sudan
21 September 2023
Nigeria’s downstream status quo changed forever with the end of fuel subsidies, but the flagship Dangote refinery has still yet to start operations
20 September 2023
Geographical position, long-term demand and decarbonisation efforts continue to support the region’s burgeoning LNG sector
19 September 2023
The special administrative region has introduced the fuel as part of its drive for carbon neutrality, but it will take years for imports to ramp up